WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 11'7601 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 16'1551 Child (under 5 years) mortality rate: 142

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 202'034  200'362  198'656  196'935  195'210  174'505  149'648  121'740 
Births 2'979  2'995  3'009  3'023  3'044  3'642  3'616  3'896 
Surviving infants 2'925  2'937  2'949  2'961  2'979  3'532  3'445  3'620 
Pop. less than 5 years 14'743  14'636  14'563  14'711  15'198  17'468  17'714  17'037 
Pop. less than 15 years 47'739  48'256  48'693  49'165  49'763  51'647  52'803  46'318 
Female 15-49 years 55'219  54'920  54'631  54'302  53'894  48'476  38'866  30'210 

Number of reported case

(Click for retrospective incidence data for Brazil)
Diphtheria 32  46  640  4'646 
Japanese encephalitis
Measles 733  220  43  68  36  61'435  99'263 
Mumps
Pertussis 7'687  5'211  5'400  2'257  477  764  15'329  45'752 
Polio* 1'342 
Rubella 8'781 
Rubella (CRS)
Tetanus (neonatal) 34  298 
Tetanus (total)** 255  213  314  333  308  346  1'547  3'098 
Yellow fever 85  27 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Brazil)
Vaccine year result method % card seen                                                
BCG 1995  93  DHS   79  99*  99*  99*  99*  99*  99*  79  56 
DTP1 1995  95  DHS   79  99*  99*  99*  99*  99*  99* 
DTP3 1995  81  DHS   79  93  97  95  99*  99  98  66  37 
DTP4          85 
IPV1          99* 
HepB_BD          88  39  99* 
HepB3          96  99*  96  98  96  94 
Hib3          95  98  94  99*  98  90 
JapEnc         
MCV1          97  99*  97  99*  98  99*  78  57 
MCV2          96  99*  96  99*  53  95 
PCV1          99  97  99* 
PCV3          93  94  88  82  24 
Pol3 1995  81  DHS   79  96  99*  96  99*  99  99*  58  69 
Rota1          91  99  97  93 
Rota_last          92  93  86  87  83 
Rubella1          99*  99*  99  99*  98 
TT2plus 1995  45  DHS   79  38  54  34  31  99* 
PAB         
VAD1         
YFV          99*  99*  99*  99*  99*  99* 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Brazil)
BCG 99  99  99  99  99  99  79  56 
DTP1 99  99  99  99  99  99  86  62 
DTP3 93  97  95  99  99  98  66  37 
HepB3 96  96  96  98  96  94 
HepB_BD 88  89  90  91  92  99 
Hib3 95  98  94  99  98  90 
MCV1 97  97  97  99  99  99  78  57 
MCV2 96  99  96  75  53  95 
PAB 93  93  93  92  92  92  63 
PCV3 93  94  88  82  24 
Pol3 96  96  96  98  99  99  58  69 
Rota_last 92  93  86  87  83 
YFV 45  44  42  37  34  37 

Number of districts in the country 5'570  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 69
From 80 to 89% 14
From 50 to 79% 14
Less than 50% 2
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
CHOLERA >= 18 years (x2 doses); Yes Military
DT 2, 4, 6 months; Yes risk groups
DTwP 15 months; 4 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HPV 9 years; +6 months; 14 years Yes
HepA 12 months; Yes
HepB_Adult >= 5 years (x3 doses); Yes
Hib 2, 4, 6 months; Yes Special groups
IPV 2, 4 months; Yes
Influenza_Adult >= 60 years; Yes and adults with chronic diseases, pregnant women, health care workers and other risk groups
Influenza_Pediatric 6 months to 4 years (x2 doses); Yes and chronic diseases
MMR 12, 15 months; Yes
MMRV Yes
MenC_conj 3, 5, 15 months; Yes '
OPV 6, 15 months; 4 years; Yes
Pneumo_conj 2, 4, 6, 12 months; Yes
Pneumo_ps >2 years; Yes special groups
Rotavirus 2, 4 months; Yes
Td >7 years (x3); 16 years; Yes every 10 years
Tdap >= 12 years; Yes For each pregnancies
Typhoid >=18 years; Yes (militaries in mission)
YF 9 months; 4 years; No where indicated

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number   2011-2016  2011-2015    2008-2011  2008-2011  2008-2011 
Nº of districts with microplans that include activities to raise immunization coverage number   5'567  5'565      5'565  5'564 

System performance

Total Nº districts in country number 5'570  5'565  5'565  5'565  5'565  5'565  5'564 
Nº districts with DTP3 coverage >=80% number 4'639  4'658  4'616  4'950  4'951  5'140  4'901 
% of districts with DTP3 coverage >=80% From 0 to 100% 83  84  83  89  89  92  88 
Nº districts with measles (MCV1) coverage >=95% number 4'284  4'194  3'413  3'369  3'354  3'872  3'365 
% of districts with MCV1 coverage >=95% From 0 to 100% 77  75  61  61  60  70  60 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.